• Advocate for cost containment policies related to comparative effectiveness, health information technology, and for policies on broader health care reform initiatives (including but not limited to S. 391). Advocate for cost containment policies related to the creation of a regulatory pathway for generic biologic medications (including but not limited to H.R. 1427, S. 726 and H.R. 1548).
• Advocate for cost containment policies related to comparative effectiveness, health information technology, and for policies on broader health care reform initiatives (including but not limited to S. 391, HR 3200).
• Advocate for cost containment policies related to the creation of a regulatory pathway for generic biologic medications (including but not limited to H.R. 1427, S. 726 and H.R. 1548).

Duration: March 12, 2007 to April 1, 2010

General Issues: Health Issues, Insurance, Pharmacy, Medicare/Medicaid

Spending: about $200,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate,, U.S. Senate, White House Office, Congressional Budget Office (CBO), Y Y

Affiliated organizations: Lussier, Gregor, Vienna & Associates